United KingdomOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2,580 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 258,477 | 285,818 |
| Total Cites | 7,287 | 7,741 |
| H-index | 32 | 33 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 2,385 | 2,508 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 5,380 | 5,561 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,000 | 6,204 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
5.86%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2,582 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 252,463 | 278,757 |
| Total Cites | 6,848 | 7,283 |
| H-index | 32 | 33 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 2,319 | 2,442 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 5,030 | 5,203 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,590 | 5,782 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
5.97%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2,565 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 247,334 | 271,612 |
| Total Cites | 6,298 | 6,715 |
| H-index | 30 | 31 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 2,197 | 2,320 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 4,602 | 4,769 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,092 | 5,271 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
6.21%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2,501 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 236,971 | 262,243 |
| Total Cites | 6,062 | 6,460 |
| H-index | 30 | 31 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 2,157 | 2,280 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 4,422 | 4,587 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,871 | 5,034 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
6.16%
|
|
Trending Researchers
Top 2% Scientists by Country
United Kingdom18,125 scientists, 3rd in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.